Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

• 期刊名称European Urology Oncology
• 作者Bellmunt, Joaquim; Esteban, Emilio; Muro, Xavier García del; Sepúlveda, Juan Manuel; Maroto, Pablo; Gallardo, Enrique; Alba, Aranzazu González del; Etxaniz, Olatz; Guix, Marta; Larriba, Jose Luis González; Arranz, Jose A.; Redrado, Miriam; Calvo, Alfonso
• 印刷ISSN2588-9311
• 文件大小379.22KB
• 发表时间2019-8
• DOI10.1016/j.euo.2019.07.014